<acronym id="1sis7"><sup id="1sis7"></sup></acronym><span id="1sis7"><sup id="1sis7"><nav id="1sis7"></nav></sup></span>
      <ruby id="1sis7"><menu id="1sis7"></menu></ruby>
      <ol id="1sis7"><output id="1sis7"></output></ol>
    1. <ol id="1sis7"><blockquote id="1sis7"></blockquote></ol>
    2. <strong id="1sis7"><output id="1sis7"></output></strong>
    3. <span id="1sis7"><blockquote id="1sis7"><nav id="1sis7"></nav></blockquote></span>

      1. <optgroup id="1sis7"><i id="1sis7"><del id="1sis7"></del></i></optgroup>
        1. SARS-CoV-2 Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method)

          May 10,2021 Zybio News

          On April 1st, SARS-CoV-2 Nucleic Acid Detection Kit (PCR-Fluorescent Probe Method) developed by Zybio obtained the medical device registration certificate of CFDA.

          PCR兩基因-注冊證.jpg

          According to the Work Manual of Nucleic Acid Testing for SARS-CoV-2 in Medical Institutions released by Joint Prevention and Control Mechanism of the State Council on December 28th, 2020, it is recommended to use reagents with high sensitivity (LoD ≤500 copies/ml) and above the double target area for detection, and use the matching VTM and extraction kits recommended in the IFU.

          image.png

          Primers and probes for SARS-CoV-2 nucleic acid detection

          Furthermore, As early as March 9th, 2020, Zybio has obtained  the CE certification of SARS-CoV-2 Nucleic Acid Detection Kit, providing VTM, automatic nucleic acid isolation system EXM3000, EXM6000, and nucleic acid extraction and detection kit for nearly 100 countries including ASEAN countries. Zybio's molecular products will continue to fight against the global COVID-19 pandemic and protect human health.

          亚洲国产精品综合久久2007,91精品国产91久久久久久无码,久久精品国产,99精品亚洲,久久94精品福利久久久久久